EQL Pharma AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 5, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Market Capitalization	135	190	107	97	94	97	Upgrade
Market Cap Growth	-14.77%	78.46%	10.31%	2.94%	-3.35%	170.17%	Upgrade
Enterprise Value	169	203	114	96	97	96	Upgrade
Last Close Price	4.50	6.58	3.39	3.35	3.15	-	Upgrade
PE Ratio	50.31	47.85	54.15	35.15	30.86	95.88	Upgrade
PS Ratio	3.73	5.53	4.65	4.18	2.38	5.55	Upgrade
PB Ratio	5.73	9.34	6.92	7.02	7.88	10.90	Upgrade
P/TBV Ratio	-	-	42.91	20.82	38.62	-	Upgrade
P/FCF Ratio	-	-	-	40.02	23.63	16.67	Upgrade
P/OCF Ratio	-	-	-	39.36	23.28	16.55	Upgrade
EV/Sales Ratio	4.63	5.90	4.99	4.14	2.47	5.47	Upgrade
EV/EBITDA Ratio	25.29	29.14	33.94	22.70	24.92	59.15	Upgrade
EV/EBIT Ratio	29.85	32.73	40.38	26.01	26.01	85.05	Upgrade
EV/FCF Ratio	-97.11	-	-	39.59	24.52	16.43	Upgrade
Debt / Equity Ratio	1.73	2.06	0.68	0.43	0.62	0.96	Upgrade
Debt / EBITDA Ratio	6.14	5.88	2.98	1.37	1.83	5.26	Upgrade
Debt / FCF Ratio	-	-	-	2.45	1.85	1.46	Upgrade
Asset Turnover	0.64	0.63	0.80	0.99	1.86	1.09	Upgrade
Inventory Turnover	1.36	1.53	1.74	2.69	7.47	3.62	Upgrade
Quick Ratio	0.98	0.97	0.53	0.83	0.77	0.56	Upgrade
Current Ratio	2.03	1.81	1.22	1.43	1.25	1.03	Upgrade
Return on Equity (ROE)	12.93%	21.63%	13.66%	22.21%	29.37%	12.04%	Upgrade
Return on Assets (ROA)	6.19%	7.12%	6.18%	9.87%	11.00%	4.39%	Upgrade
Return on Capital (ROIC)	7.33%	8.64%	7.85%	12.27%	12.84%	5.03%	Upgrade
Return on Capital Employed (ROCE)	9.80%	11.50%	15.40%	24.50%	27.90%	10.60%	Upgrade
Earnings Yield	1.99%	2.09%	1.85%	2.84%	3.24%	1.04%	Upgrade
FCF Yield	-1.29%	-1.49%	-1.01%	2.50%	4.23%	6.00%	Upgrade
Buyback Yield / Dilution	-3.09%	-0.34%	-0.91%	-1.59%	-	3.37%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.